BA
AGN

Birinyi Associates’s Allergan plc AGN Stock Holding History

Birinyi Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,000
Closed -$231K – 91
2016
Q2 		$231K Sell
1,000
-500
-33% -$115K 0.1% 75
2016
Q1 		$402K Sell
1,500
-1,200
-44% -$344K 0.18% 66
2015
Q4 		$844K Buy
2,700
+1,000
+59% +$298K 0.55% 47
2015
Q3 		$462K Buy
1,700
+200
+13% +$61.4K 0.2% 67
2015
Q2 		$455K Sell
1,500
-1,450
-49% -$432K 0.31% 59
2015
Q1 		$878K Buy
+2,950
New +$841K 0.58% 42

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Birinyi Associates's AGN Position: Q3 2016 in Review

Birinyi Associates sold out of Allergan plc (AGN) in Q3 2016, closing a stake of 1,000 shares — an estimated $231K sold.

Birinyi Associates first reported a position in AGN in Q1 2015 and held it in 6 quarters. The position peaked at $878K in Q1 2015. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

  • Birinyi Associates reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
  • Birinyi Associates sold 1,000 Allergan plc shares in Q3 2016, an estimated $231K.
  • Birinyi Associates first reported a position in Allergan plc in Q1 2015 and held it in 6 quarters.
  • Birinyi Associates's Allergan plc position peaked at $878K in Q1 2015.
  • 1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Birinyi Associates's 13F filing for Q3 2016, filed 10 Nov 2016.